Facebook
Twitter
LinkedIn
ForwardSHEA Journal Reviewer Program 2025
ICHE and ASHE are the official publications of the Society for Healthcare Epidemiology of America (SHEA). The journal is written by healthcare epidemiology, infection control and antimicrobial stewardship experts and epidemiologists and is guided by its editorial boards. The journal editors thank you for being a reviewer! Earn your CME credit today.
CME Credit for ICHE and ASHE Reviewers
- ICHE and ASHE Editors invite you to become a reviewer and earn CME.
- Already a reviewer? Earn credit easily while completing your next review.
- Interested in becoming a Reviewer? Find out how!
Needs Assessment Statement
The Society for Healthcare Epidemiology of America (SHEA) has a responsibility to maintain an ongoing knowledge and understanding of the most current issues in healthcare epidemiology, infection prevention, and antimicrobial stewardship, ensuring that physicians and other healthcare practitioners provide the highest standards of patient care. One method of maintaining this standard is through the manuscript review process. The review of manuscripts being considered for publication in SHEA's journals, Infection Control & Hospital Epidemiology (ICHE) and Antimicrobial Stewardship & Healthcare Epidemiology (ASHE) offers reviewers an opportunity to refine their skills in performing critical analyses of the literature. Such reviews ultimately enhance the quality of published science by ensuring expert assessment of evidence-based practices in infection prevention and stewardship, conducted through a mechanism free from conflict of interest.
Target Audience
The target audience includes physicians in clinical practice, research, and public health who are active in multidisciplinary fields such as infectious diseases, internal medicine, healthcare epidemiology, microbiology, pediatrics, and antimicrobial stewardship.
Learning Objectives
- Demonstrate skills in performing critical analyses of the medical literature, and maintain knowledge of current issues and developments in epidemiology, infection prevention, and stewardship practices.
- Conduct an appropriate review of the literature related to the proposed manuscript and, when available, a review of the evidence-based clinical data related to the proposed manuscript.
- Prepare a confidential review without conflict of interest.
- Produce a standardized, concise, constructive and timely evaluation that is balanced and objective avoiding any personal comments.
- Synthesize the review of literature with a thorough review of the proposed manuscript thereby identifying its strengths and areas needing improvement prior to publication.
Privacy Policy
See how we collect and use information you submit by visiting our privacy policy page.
In accordance with the Accreditation Council for Continuing Medical Education's (ACCME) Standard for Integrity and Independence in Accredited Continuing Education, all faculty and planning partners must disclose all financial relationship(s) with any ineligible company within the prior 24 months for any amount. SHEA identifies and mitigates all conflict of interest prior to delivering the educational activity to learners.
ICHE
Editor-in-Chief
David P. Calfee, MD, MS
New York, NY, USA
No relevant financial relationships to disclose
No relevant financial relationships to disclose
Deputy Editor
David J. Weber, MD, MPH
Chapel Hill, NC, USA
*Consultant: Pfizer, GSK, BD, PDI
*Consultant: Pfizer, GSK, BD, PDI
*Speaker: Pfizer, Merk, GAMA
*Adjudication Board: Moderna
Associate Editors
Westyn Branch-Elliman, MD, MMSc
Boston, MA, USA
*Consultant: DLA Piper, LLC/Medtronic
Tara N. Palmore, MD
Washington, D.C., USA
No relevant financial relationships to disclose
No relevant financial relationships to disclose
Joshua K. Schaffzin, MD, PhD
Ottawa, ON, Canada
Ottawa, ON, Canada
No relevant financial relationships to disclose
Trevor C. Van Schooneveld, MD
Omaha, NE, USA
*Contracted Research: AN2 Therapeutics, Biomerieux
*Contracted Research: AN2 Therapeutics, Biomerieux
*Consultant: Biomerieux
ASHE
Editor-in-Chief
Gonzalo Bearman, MD, MPH
Virginia Commonwealth University, US
No relevant financial relationships to disclose
Deputy Editor
Priya Nori, MD
Albert Einstein College of Medicine, USA
No relevant financial relationships to disclose
Associate Editors
Anucha Apisarnthanarak, MD
Thammasart University Hospital, Thailand
No relevant financial relationships to disclose
Bradley Langford, PharmD, MPH
Antimicrobial Stewardship Pharmacist Lead, Hotel Dieu Shaver Health and Rehabilitation Centre
No relevant financial relationships to disclose
Alexandre R. Marra, MD
Hospital Israelita Albert Einstein, Brazil and University of Iowa Hospitals and Clinics, USA
No relevant financial relationships to disclose
Kelly L. Matson, PharmD
University of Rhode Island, College of Pharmacy, USA
No relevant financial relationships to disclose
Oluchi Mbamalu, BPharm, MPharm, PhD
University of the Western Cape (UWC), Capetown, South Africa
No relevant financial relationships to disclose
Kari Simonsen, MD, MBA
University of Nebraska Medical Center, USA
*Contracted Research: Pfizer, Melinta Therapeutics
Pranavi Sreeramoju, MD, MPH, MBA
University of Texas Southwestern Medical Center, USA
No relevant financial relationships to disclose
*All relevant financial relationships listed have been mitigated
Accreditation Statements
In support of improving patient care, The Society for Healthcare Epidemiology of America is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIANS:
SHEA designates this manuscript review activity for a maximum of 3.0 AMA PRA Category 1 Credit(s)™ with a maximum of 15 credits per year. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Privacy Policy
See how we collect and use information you submit by visiting our privacy policy page.
Available Credit
- 15.00 AMA PRA Category 1 Credit™
Price
Cost:
$0.00
Select each available object in the course and click "Enroll". Once enrolled, click the next available review in the course outline. If it is your first time completing a manuscript review for 2025, select 'Review 1'.
------
You will earn 3.00 AMA PRA Category 1 Credit™ per month evaluation completed. You may complete up to five month evaluations for a maximum of 15.00 AMA PRA Category 1 Credit.™
Responsibility of the Reviewers
The critical and confidential review of manuscripts is an essential element of research publications. Among the obligations of reviewers is the commitment to providing an expert, critical, and constructive scientific and literary appraisal of research reports in their fields of knowledge, skills, and experience in a fair and unbiased manner. In order to facilitate the prompt sharing of scientific results, it is also the obligation of each reviewer to complete their assignments promptly, within the editor's deadline.
Interested in becoming a Reviewer?
Please contact Lindsay MacMurray at [email protected]